EE57 Healthcare Costs Avoided in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura with Caplacizumab in Colombia

Abstract

Authors

S. Londono Y. Gil-Rojas P. Lasalvia

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×